Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas

NCT03582007 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Safety data review

Conditions

Pneumonia

Interventions

DRUG: Murepavadin
DRUG: One anti-pseudomonal antibiotic

Sponsor

Polyphor Ltd.